Home/Filings/4/0001209191-17-047503
4//SEC Filing

Needham Thomas E. Jr. 4

Accession 0001209191-17-047503

CIK 0001274792other

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 6:28 PM ET

Size

5.5 KB

Accession

0001209191-17-047503

Insider Transaction Report

Form 4
Period: 2017-08-01
Needham Thomas E. Jr.
Chief Business Officer
Transactions
  • Award

    Stock Option (right to buy)

    2017-08-01+450,000450,000 total
    Exercise: $1.28Exp: 2027-07-31Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 1/6th of the total number of shares granted on 1/24/18 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 7/24/20.

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeother

Related Parties

1
  • filerCIK 0001712568

Filing Metadata

Form type
4
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 6:28 PM ET
Size
5.5 KB